CLOV vs TMHC · rev $1.37B vs P/E 11, rev $8.17B
Clover Health Investments Corp (CLOV) versus Taylor Morn Home (TMHC) — a side-by-side from cached financials, not a winner call.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
Taylor Morn Home (TMHC) is a residential construction company listed on NYSE.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
Latest reported TMHC revenue for 2024-12-31 was $8.17B. Net income was $886.6M. Revenue was up 10.1% from 2023-12-31 to 2024-12-31. TMHC currently screens at market cap $6.59B and trailing P/E 10.7.
CLOV currently screens at market cap $1.55B. TMHC currently screens at market cap $6.59B and trailing P/E 10.7.
Not investment advice. Open the CLOV and TMHC stock pages for the full models.
Not investment advice.